Stock listing
CV Stock Price, News, Filings & Events — Capsovision, Inc.
Selected listing: CV · BOATS · USD · US
This page tracks Capsovision, Inc.'s CV:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CV:BOATS. CV:BOATS is the stock-level entry point for investors researching Capsovision, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Capsovision, Inc. (ticker: CV) is a public company based in the United States with a market capitalization of approximately $324.3 million. The company is focused on developing innovative solutions in its industry. As a publicly traded entity, it is subject to regulatory requirements and provides transparency to its investors.
- Ticker
- CV:BOATS
- Asset type
- Stock
- Market cap
- $296.8M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- BOATS
- Currency
- USD
Capsovision, Inc. CV:BOATS stock context
This page tracks Capsovision, Inc.'s CV:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CV:BOATS. CV:BOATS is the stock-level entry point for investors researching Capsovision, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Capsovision, Inc. (ticker: CV) is a public company based in the United States with a market capitalization of approximately $324.3 million. The company is focused on developing innovative solutions in its industry. As a publicly traded entity, it is subject to regulatory requirements and provides transparency to its investors.
Latest news from Capsovision, Inc.
CapsoVision Reports Second Quarter 2026 Financial Results
August 13, 2026
CapsoVision® Announces International Launch of AI Highlights
August 3, 2026
CapsoVision to Release Second Quarter 2026 Financial Results on August 13, 2026
July 30, 2026
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors
July 2, 2026
CapsoVision Reports First Quarter 2026 Financial Results
May 14, 2026
Capsovision, Inc. earnings calls
CapsoVision, Inc. (CV) Q2 2026 Earnings Call
August 13, 2026 · Replay with transcript and chapters
CapsoVision, Inc. (CV) Q1 2026 Earnings Call
May 14, 2026 · Replay with transcript and chapters
CapsoVision, Inc. (CV) Q4 2025 Earnings Call
March 26, 2026 · Replay with transcript and chapters
CapsoVision, Inc. (CV) Q3 2025 Earnings Call
November 13, 2025 · Replay with transcript and chapters
CapsoVision, Inc. (CV) Q2 2025 Earnings Call
August 14, 2025 · Replay with transcript and chapters
Research Capsovision, Inc.
Capsovision, Inc. investor report
Review AI stock analysis and investor report context for CV:BOATS.
Capsovision, Inc. company profile
View the public company page for Capsovision, Inc. on 6ix.
Capsovision, Inc. news
Read company news and market updates connected to Capsovision, Inc..
Capsovision, Inc. investor events
Find investor webinars, events, and replay context for Capsovision, Inc..
Alternate listings
CV:NASDAQ
US · USD
Alternate listing for Capsovision, Inc.; the primary context on this page is CV:BOATS.
H6U:FWB
DE · EUR
Alternate listing for Capsovision, Inc.; the primary context on this page is CV:BOATS.
H6U:MUN
DE · EUR
Alternate listing for Capsovision, Inc.; the primary context on this page is CV:BOATS.
H6U:DUS
DE · EUR
Alternate listing for Capsovision, Inc.; the primary context on this page is CV:BOATS.